Symtuza 150 mg

SYMTUZA 150 MG tablets contain cobicistat, a medication used to support HIV treatment. This oral tablet is manufactured by Janssen Inc. in Canada and is available in a 30-tablet pack.

SYMTUZA 150 MG tablets are used as part of a combination therapy for HIV-1 infection in adults. Cobicistat, the active ingredient, is a pharmacokinetic enhancer that helps other HIV medications work more effectively. This medication is typically prescribed alongside other antiretroviral drugs to manage HIV. What is SYMTUZA used for? It is used to support the treatment of HIV-1 infection in adults.

Common effects of SYMTUZA 150 MG tablets may include headaches, nausea, and fatigue. Some individuals might experience changes in liver function tests. It is important to discuss any persistent or severe side effects with a healthcare provider.

SYMTUZA 150 MG tablets should be handled with care. Store the medication at room temperature, away from moisture and heat. Follow the prescribed dosage and administration instructions provided by a healthcare professional. Do not share this medication with others.

SYMTUZA 150 MG tablets can interact with various medications, including those metabolized by the liver's cytochrome P450 system. It is important to inform your healthcare provider about all medications, supplements, and herbal products you are taking. Avoid consuming alcohol while using this medication, as it may increase the risk of side effects.